"Fight Flu Without Pain"

Return to Vaccination News Home Page __» Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

The Food and Drug Administration recently approved FluMist, an influenza vaccine that is squirted up the nose instead of injected--a method that may appeal to patients who dislike needles and could possibly reduce the number of serious illnesses. FluMist has only been approved for healthy patients ages five to 49 years, with further tests to be made before the approval can be widened, but public health officials hope that the new option will also reduce shortages of the injectable vaccine. FluMist is made from weakened live viruses and will cost approximately $46 instead of the $10 to $15 of the injectable vaccine, but Dr. Jay M. Lieberman, head of pediatric infectious diseases at Miller Children's Hospital in Long Beach, Calif., also notes that because FluMist "is a live viral vaccine that replicates in the nose ... you get more local immunity." The federal Vaccine for Children program has apparently not yet said how much it will cover FluMist for public health use in the upcoming influenza season.

Return to Vaccination News Home Page __» Right-click to "open in new window"

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.